How to Buy Ocular Therapeutix Stock
Ocular Therapeutix Inc
Ocular Therapeutix, Inc. , a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology.
Ocular Therapeutix stock last closed at $11.82, up 2.96% from the previous day, and has increased 6.68% in one year. It has overperformed other stocks in the Biotechnology industry by 0.3 percentage points. Ocular Therapeutix stock is currently +104.32% from its 52-week low of $5.79, and -14.66% from its 52-week high of $13.85.
As of Oct 30, 2025, there are 174M shares of OCUL outstanding. The market value of OCUL is $2.06B. In the past 24 hours, 2.85M OCUL shares were traded.
How to Buy Ocular Therapeutix Stock
Wondering how to invest in Ocular Therapeutix stock? Here's how.
- Choose where to buy Ocular Therapeutix stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you determine where to buy Ocular Therapeutix stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Pick your payment method and add your info.
- Analyze Ocular Therapeutix stock: The Ocular Therapeutix ticker symbol is OCUL. Is Ocular Therapeutix stock a good investment? Should you buy shares of OCUL? How do OCUL's underlying business fundamentals look? Do top analysts think Ocular Therapeutix is a good buy? Why has OCUL's stock price moved recently? (Hint: Our stock analysis website can help you figure out if OCUL is a good stock to buy).
- Execute your OCUL trade: Decide if you will purchase OCUL shares at the current market price or use a limit order to purchase OCUL stock at a particular price.
- Watch your investment in OCUL: Create a watchlist to get live updates on your investment in Ocular Therapeutix shares.
Step 1: Choose where to buy Ocular Therapeutix stock
You need a brokerage account in order to access the NASDAQ market and buy OCUL shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal information so you are able to buy OCUL today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open your new brokerage account.
- Send your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have filled out your info on the greatest app to buy stocks, you need to deposit funds:
Check out the video below to see the process of transferring money into your investment account.
Step 4: Analyze Ocular Therapeutix stock
After you have chosen the best place to buy Ocular Therapeutix stock, it's very important to analyze their stock prior to investing, so you can wrap your head around the risk as well as the upside.
Ocular Therapeutix shares at a glance
Ocular Therapeutix Fundamentals
WallStreetZen was designed to help average investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on OCUL's stock page.
Is OCUL stock undervalued?
Investors use many financial metrics, analyses, models, and charts to gauge OCUL's true value.
Using relative valuations ratios:
- OCUL could be overvalued based on its P/B ratio of 6.72x, relative to Biotechnology industry P/B ratio of 4.97x
You can access additional valuation analysis on OCUL's stock here.
OCUL Financial Summary
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the OCUL balance sheet.
- There are more short-term assets than long-term liabilities on the OCUL balance sheet.
- Total OCUL debt is lower than 5 years ago, relative to shareholder equity.
- OCUL has cash burn of 179236000. It has sufficient cash and short-term investments to cover this for at least one year.
Negative Health Checks:
- OCUL has $392.75M in cash and short term investments. This is not enough to cover its annual cash burn of $179.24M.
- OCUL has a relatively high debt to equity ratio of 0.48.
- OCUL profit margin has gone down from -226.5% to -382.5% in the past year.
Do analysts think it's a good time to buy Ocular Therapeutix stock
Out of 8 Wall Street analysts who give forecasts on OCUL, the consensus analyst rating on OCUL is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Latest OCUL Analyst Forecasts
Serge Belanger, a top 2% analyst from Needham maintains OCUL with a buy rating and raises their OCUL price target from $15.00 to $20.00, on Oct 1, 2025.
Jonathan Wolleben, a top 4% analyst from JMP Securities maintains OCUL with a buy rating and raises their OCUL price target from $20.00 to $29.00, on Oct 1, 2025.
Greg Harrison, a top 6% analyst from ScotiaBank maintains OCUL with a buy rating and lowers their OCUL price target from $22.00 to $20.00, on Aug 6, 2025.
You can dive deeper into what analysts are forecasting on the Ocular Therapeutix stock forecast page.
OCUL Technicals
How is OCUL performing as a company?
Last year, OCUL revenue was $56.66M. In the past 5 year, OCUL's revenue has increased by 50.81% per year. This was slower than the Biotechnology industry average of 70.04%.
Find out more about OCUL's earnings and revenue performance here.
Who is buying/selling OCUL?
Over the last 12 months, executives and large shareholders at OCUL have sold more shares than they have bought.
Todd Anderman, Chief Legal Officer of OCUL, was the latest OCUL insider to sell. They sold $137,368.88 worth of OCUL stock on Oct 8, 2025.
Research more about who owns OCUL shares here.
Can I rely on OCUL as an income stream?
No, Ocular Therapeutix doesn't provide an income stream by paying out dividends.
What do other traders have to say about OCUL?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your OCUL trade
There are two primary options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the best for newer investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount, place a limit order.
Click the Open Trade button and your broker will execute the order.
If you need more info about investing in stocks on eToro, watch the how to video below:
Step 6: Watch your investment in OCUL
Now that you own some OCUL stock, you'll want to stay up-to-date on your new company.
Add OCUL to a watchlist to get notified of the latest news about your OCUL stock.
OCUL Feed
How to Buy Stock in Ocular Therapeutix
To summarize, here are the 6 steps for buying Ocular Therapeutix stock:
- Choose where to buy Ocular Therapeutix stock
- Create a brokerage account
- Put funds into your brokerage account
- Analyze Ocular Therapeutix stock
- Execute your OCUL trade
- Watch your investment in OCUL
If you are looking for a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Ocular Therapeutix, create a watchlist on WallStreetZen today.
Trending "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.